248 related articles for article (PubMed ID: 21073664)
1. Prediction and prevention of Type 1 diabetes mellitus.
Zhang L; Eisenbarth GS
J Diabetes; 2011 Mar; 3(1):48-57. PubMed ID: 21073664
[TBL] [Abstract][Full Text] [Related]
2. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
Tsirogianni A; Pipi E; Soufleros K
Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
[TBL] [Abstract][Full Text] [Related]
4. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
Franke B; Galloway TS; Wilkin TJ
Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
[TBL] [Abstract][Full Text] [Related]
5. [Latest overview of type 1 diabetes mellitus].
Miura J; Uchigata Y
Nihon Rinsho; 2008 Jul; 66(7):1397-404. PubMed ID: 18616134
[TBL] [Abstract][Full Text] [Related]
6. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
[TBL] [Abstract][Full Text] [Related]
7. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.
Dereke J; Nilsson C; Landin-Olsson M; Hillman M
Diabet Med; 2012 Dec; 29(12):e436-9. PubMed ID: 22924602
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in Type 1 diabetes.
Schmidt KD; Valeri C; Leslie RD
Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
11. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
[TBL] [Abstract][Full Text] [Related]
12. Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.
Dunseath G; Ananieva-Jordanova R; Coles R; Powell M; Amoroso M; Furmaniak J; Smith BR; Dayan C; Luzio S
Clin Chim Acta; 2015 Jul; 447():90-5. PubMed ID: 26006309
[TBL] [Abstract][Full Text] [Related]
13. Dual-parameter model for prediction of type I diabetes mellitus.
Eisenbarth GS; Gianani R; Yu L; Pietropaolo M; Verge CF; Chase HP; Redondo MJ; Colman P; Harrison L; Jackson R
Proc Assoc Am Physicians; 1998; 110(2):126-35. PubMed ID: 9542768
[TBL] [Abstract][Full Text] [Related]
14. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
Yi B; Huang G; Zhou ZG
Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
[TBL] [Abstract][Full Text] [Related]
15. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
16. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.
Petruzelkova L; Ananieva-Jordanova R; Vcelakova J; Vesely Z; Stechova K; Lebl J; Dusatkova P; Sumnik Z; Coles R; Powell M; Furmaniak J; Rees Smith B; Kolouskova S
Diabet Med; 2014 Feb; 31(2):165-71. PubMed ID: 23952619
[TBL] [Abstract][Full Text] [Related]
17. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
[TBL] [Abstract][Full Text] [Related]
19. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
Beyan H; Ola T; David R; Leslie G
Ann N Y Acad Sci; 2006 Oct; 1079():81-9. PubMed ID: 17130535
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
